Picture of Cryo-Cell International logo

CCEL — Cryo-Cell International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Cryo-Cell International Q3 net income, EPS rise

((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
    
Overview
    * US cord blood bank's fiscal Q3 revenue was flat yr/yr
    * Net income and EPS rose yr/yr in fiscal Q3

    
Outlook
    * Company did not provide specific financial guidance for future periods

    
Result Drivers
    FLAT REVENUE - Co did not provide specific reasons for its financial results
    * HIGHER NET INCOME - Co did not attribute net income increase to specific factors

    
Company press release:  ID:nBw8rBtBDa 
    
Key Details
 Metric    Beat/Mis  Actual    Consensu
           s                   s
                               Estimate
 Q3                  $7.82      
 Revenue             mln       
 Q3 EPS              $0.16      
 Q3 Net              $1.27     
 Income              mln       
    
Analyst Coverage
    * The one available analyst rating on the shares is "hold"
    * The average consensus recommendation for the healthcare facilities & services peer group is "buy."

    
Reuters Recommended Reads
    * Oct 9 - Bagel franchisor BAB's Q3 net income rises 36% on lower overhead costs
    * Oct 7 - Consulting firm Resources Connection's Q1 net loss widens on lower project volume
    * Oct 7 - Cosmos Health Q3 revenue rises to record high on contract manufacturing

    
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .

    (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cryo-Cell International

See all news